High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial (2017)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1373/clinchem.2016.264788
- Subjects: BIOMARCADOR; TROPONINA; DOENÇAS CARDIOVASCULARES; ARTERIOSCLEROSE
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2017
- Source:
- Título do periódico: Clinical Chemistry
- ISSN: 0009-9147
- Volume/Número/Paginação/Ano: v. 63, n. 1, p. 307-315, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
EISEN, Alon; BONACA, Marc P.; SCIRICA, Benjamin M.; et al. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry, Washington, v. 63, n. 1, p. 307-315, 2017. Disponível em: < http://clinchem.aaccjnls.org/content/63/1/307.full.pdf > DOI: 10.1373/clinchem.2016.264788. -
APA
Eisen, A., Bonaca, M. P., Scirica, B. M., White, H. D., Tendera, M., Dellborg, M., et al. (2017). High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry, 63( 1), 307-315. doi:10.1373/clinchem.2016.264788 -
NLM
Eisen A, Bonaca MP, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KAA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial [Internet]. Clinical Chemistry. 2017 ; 63( 1): 307-315.Available from: http://clinchem.aaccjnls.org/content/63/1/307.full.pdf -
Vancouver
Eisen A, Bonaca MP, Scirica BM, White HD, Tendera M, Dellborg M, Nicolau JC, Morais J, Fox KAA, Bohula EA, Murphy SA, Braunwald E, Morrow DA. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial [Internet]. Clinical Chemistry. 2017 ; 63( 1): 307-315.Available from: http://clinchem.aaccjnls.org/content/63/1/307.full.pdf - Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial
- Gravidez em Portadora de Doença de Kawasaki com Múltiplos Aneurismas de Artérias Coronárias [Editorial]
- Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction a randomized clinical trial
- Síndrome coronária aguda com supradesnível do segmento ST
- Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial
- Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
- Ticagrelor in patients with stable coronary disease and diabetes
- Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
- Alirocumab reduces total hospitalizations and increases days alive and out of Hospital in the ODYSSEY OUTCOMES Trial
- Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial
Informações sobre o DOI: 10.1373/clinchem.2016.264788 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
